financetom
Business
financetom
/
Business
/
P10 Q3 revenue up 2% on fee-paying AUM increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
P10 Q3 revenue up 2% on fee-paying AUM increase
Nov 6, 2025 3:59 AM

Overview

* P10 Q3 revenue rose 2% yr/yr but missed analyst expectations

* Adjusted net income for Q3 beats analyst estimates

* Company repurchased 110,032 shares at $11.34 each

Outlook

* P10 expects to close the year with $5 bln in fundraising, higher than previously forecast

Result Drivers

* FEE-PAYING AUM GROWTH - Fee-paying AUM increased by 17% yr/yr, contributing to revenue growth

* ADJUSTED NET INCOME BEAT - Adjusted net income of $28.6 mln exceeded analyst estimates of $13.2 mln

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $75.90 $77.65

Revenue mln mln (2

Analysts

)

Q3 EPS $0.02

Q3 Beat $28.60 $13.20

Adjusted mln mln (2

Net Analysts

Income )

Q3 Net $3 mln

Income

Q3 $0.04

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the investment management & fund operators peer group is "buy"

* Wall Street's median 12-month price target for P10 Inc ( PX ) is $13.00, about 18.6% above its November 5 closing price of $10.58

* The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alterity Therapeutics Says ATH434 Showed Slowing of Clinical Progression in Phase 2 Multiple System Atrophy Study; Shares Up
Alterity Therapeutics Says ATH434 Showed Slowing of Clinical Progression in Phase 2 Multiple System Atrophy Study; Shares Up
Jan 30, 2025
09:39 AM EST, 01/30/2025 (MT Newswires) -- Alterity Therapeutics ( ATHE ) shares were sharply higher Thursday morning after the company said that its ATH434 lead candidate demonstrated 48% slowing of clinical progression in a phase 2 clinical trial in patients with early-stage multiple system atrophy. The result was achieved at the 50 mg dose at week 52 when compared...
Baker Hughes Awarded LNG Contract From Venture Global
Baker Hughes Awarded LNG Contract From Venture Global
Jan 30, 2025
09:36 AM EST, 01/30/2025 (MT Newswires) -- Baker Hughes ( BKR ) said Thursday that it has been awarded a contract to provide a liquefied natural gas system and power island to support Venture Global's ( VG ) LNG projects in the US. Baker Hughes ( BKR ) also said it signed a multi-year services frame agreement to provide maintenance,...
Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Jan 30, 2025
LONDON, Jan 30 (Reuters) - Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a www.clinicaltrials.gov entry. The Danish drugmaker last month revealed disappointing results in a late-stage trial of CagriSema, wiping as much as $125 billion off its market value. It said then that it would initiate a...
Wells Fargo Names Fernando Rivas Sole CEO of CIB Unit as Jon Weiss Steps Down
Wells Fargo Names Fernando Rivas Sole CEO of CIB Unit as Jon Weiss Steps Down
Jan 30, 2025
09:38 AM EST, 01/30/2025 (MT Newswires) -- Wells Fargo ( WFC ) said Thursday that Fernando Rivas will become the sole chief executive of its Corporate & Investment Banking, or CIB, division as Jon Weiss steps down immediately and plans to retire on June 1. Weiss has been with the company for about 20 years, Wells Fargo ( WFC )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved